-
STAT News – Biotech3 weeks agoSTAT+: Sepsis hospitalizations have tripled in Massachusetts. Is it real or a billing game?
It can come seemingly out of nowhere: a patient gets an infection — in the lungs, bladder, or pretty much anywhere — and the body’s immune...
-
STAT News – Biotech3 weeks agoSTAT+: Inside the delicate, high-stakes search for a new CDC director
At first glance, it’s a plum job that touches the lives of every American: director of the Centers for Disease Control and Prevention, running the sprawling...
-
STAT News – Biotech3 weeks agoSTAT+: ACIP conflict is test of Trump’s support for RFK Jr.’s vaccine policy overhaul
WASHINGTON — Federal health officials are weighing how to respond to a court ruling that stalled major parts of health secretary Robert F. Kennedy Jr.’s vaccine...
-
STAT News – Biotech3 weeks agoSTAT+: Medicare chief says TrumpRx is meant to be narrow in scope
At yesterday’s STAT Breakthrough Summit East, Medicare chief Chris Klomp offered a tempered view of TrumpRx, and an MSK cell therapy expert warned that China’s more...
-
STAT News – Biotech3 weeks agoSTAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send...
-
STAT News – Biotech3 weeks agoA conversation with the ‘godfather’ of biotech
On this week’s episode of “The Readout LOUD,” we bring you a special conversation with Stelios Papadopolous, also know as the “godfather” of biotech. He sat...
-
STAT News – Biotech3 weeks agoSTAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to...
-
STAT News – Biotech3 weeks agoSTAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
LONDON — U.K. health officials on Friday said they had reopened a review of two new Alzheimer’s therapies after previously finding they did not provide good...
-
STAT News – Biotech3 weeks agoSTAT+: A family’s giving to the Broad Institute’s research tops $1 billion
The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and...
-
STAT News – Biotech3 weeks agoTobacco could get a boost from the farm bill. How does that square with MAHA?
The 2026 farm bill now working its way through Congress contains a number of provisions at odds with the Make America Healthy Again movement, particularly when...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
